Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Takeda Pharmaceutical Co. Ltd.

http://www.takeda.com

Latest From Takeda Pharmaceutical Co. Ltd.

Keeping Track: Takeda’s Exkivity Clears US FDA; BeiGene’s Busy Summer

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker

US FDA Performance Tracker Approvals

Missed Review Deadlines Are Reminder That On-Time Approvals Are A Goal, Not A Guarantee

After more than a decade of sky-high rates of on-time regulatory action by the US FDA, missed user fee goal dates are back in a pretty big way – and it’s not just JAK inhibitor and COVID-19 delays.

US FDA Performance Tracker Drug Review

Aerie Misses Quick Path To Dry Eye Approval, But Is Still Moving Forward

AR-15512 missed the primary endpoints in a Phase IIb dry eye disease study that could have served as a pivotal trial, but Aerie’s drug hit enough signs and symptoms of the disease to justify a Phase III.

Clinical Trials Drug Approval Standards

Finance Watch: Lightstone Ventures Closes $375m Fund To Back Early Stage Biotechs

Private Company Edition: Recent biopharma venture capital financings add up to $1.7bn, including a $135m crossover round for HilleVax after spinning out of Takeda in July to advance a norovirus vaccine, Skyhawk’s $133m in fresh funding and Obsidian’s $115m series B round.

Financing Innovation
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Altos Therapeutics LLC
    • AR Scientific, Inc. (URL)
    • ARIAD Pharmaceuticals, Inc.
    • Bradley Pharmaceuticals, Inc
    • Cellerix SA
    • Cerevance, Envoy Therapeutics, Inc.
    • Chordia Therapeutics
    • ChromaJean, Inc.
    • IDM Pharma
    • Intellikine, Inc.
    • Inviragen, Inc.
    • LigoCyte Pharmaceuticals, Inc.
    • Maverick Therapeutics, Inc.
    • Millennium Pharmaceuticals, Inc.
    • Mutual Pharmaceutical Company, Inc. (URL)
    • Neutec
    • Nihon Pharmaceutical Co., Ltd
    • Nycomed Pharma AS
    • Pharmaceutical Holdings Corporation (URL)
    • PvP Biologics, Inc.
    • sanaplasma AG
    • Syrrx, Inc.
    • TAP Pharmaceutical Products, Inc.
    • Teva Takeda Pharma Ltd.
    • Shire Pharmaceuticals Group PLC (SHPG)
    • Teva Takeda Yakuhin Ltd.
    • TiGenix NV
    • URL Pharma, Inc. Advanced BioHealing, Inc. (renamed Shire Regenerative Medicine)
    • AesRX LLC
    • Baxalta Incorporated
    • BIKAM Pharmaceuticals Inc.
    • Chatham Therapeutics
    • Dyax Corp.
    • FerroKin BioSciences, Inc.
    • Fibrotech Therapeutics
    • Foresight Biotherapeutics Inc.
    • Gambro AB
    • Immuno-US
    • Jerini AG
    • Lotus Tissue Repair
    • Lumena Pharmaceuticals
    • Meritage Pharma, Inc.
    • Movetis NV
    • New Pervasis Therapeutics, Inc.
    • NPS Pharmaceuticals, Inc.
    • Premacure AB
    • Prism Pharmaceuticals, Inc.
    • River Pharmaceuticals
    • Roberts Pharmaceutical Corporation
    • SARcode Corporation
    • SuppreMol GmbH
    • Synovis Life Technologies, Inc.
    • Transkaryotic Therapies, Inc.
    • ViroPharma Inc.
UsernamePublicRestriction

Register